Records containing: Stage IV Renal Cell Cancer

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2015-05-25
Phase I/II Trial Of Low Dose Suramin (CI-1003, NSC#34936) And 5-Fluorouracil In Patients With Metastatic Renal Cell Carcinoma (RCC)
CLINICAL_TRIALS study record update · 2015-02-04
Phase II Study of MLN518 in Patients With Metastatic Clear Cell Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2014-12-23
A Phase 1, Pharmacokinetic and Pharmacodynamic Study of the Combination of RO4929097 and Cediranib in Patients With Advanced Solid Tumors
CLINICAL_TRIALS study record update · 2014-09-11
A Phase I/II Trial of CCI-779 and Bevacizumab in Stage IV Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2014-06-11
A Phase I, and Biologic Correlative Study of Erlotinib, in Combination With Cetuximab and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2014-05-30
Safety and Efficacy of RO4929097 in Combination With Temsirolimus: A Pharmacokinetic and Pharmacodynamic Phase I Study in Patients With Advanced Solid Tumours With an Expansion of Cohort With Patients With Recurrent/Metastatic Endometrial and Renal Cell Cancers
CLINICAL_TRIALS study record update · 2014-04-02
Phase I Pharmacodynamic Trial of Sequential Sunitinib With Bevacizumab in Patients With Renal Cell Carcinoma and Other Advanced Solid Malignancies
CLINICAL_TRIALS study record update · 2014-03-17
A Phase 1/Pharmacokinetic Study of Sunitinib in Patients With Cancer Who Also Have HIV and Are on HAART Therapy
CLINICAL_TRIALS study record update · 2014-02-24
A Phase I Study and Pharmacological Trial of Once Weekly Aminoflavone Prodrug (AFP464) Administered 3 Out of Every 4 Weeks in Solid Tumor Patients
CLINICAL_TRIALS study record update · 2014-01-14
A Phase I and a Randomized Phase II Study of Maximal Angiogenic Blockade in Advanced Renal Carcinoma: Bevacizumab (NSC-704865) With or Without MEDI-522 (NSC-719850)
CLINICAL_TRIALS study record update · 2013-11-20
A Phase 2 Study of AZD2171 in Patients With Advanced Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2013-08-30
A Phase II, Pharmacokinetic and Biologic Correlative Study of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Renal Cell Carcinoma (RCC)
CLINICAL_TRIALS study record update · 2013-08-26
A Phase II Trial of G3139 (Genasense) Anti-Bcl-2 Antisense Oligonucleotide Plus Alpha-Interferon in Metastatic Renal Cancer
CLINICAL_TRIALS study record update · 2013-07-30
Phase 2 Trial of Sequential Bevacizumab Then Subcutaneous Interleukin-2 in Metastatic Renal Cancer
CLINICAL_TRIALS study record update · 2013-07-10
Phase II Study of BAY 56-3722 in Patients With Recurrent, Unresectable, or Metastatic Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2013-07-02
A Phase 2 Study Of BAY 43-9006 In Combination With Interferon Alfa-2b In Metastatic Renal Cell Cancer
CLINICAL_TRIALS study record update · 2013-06-28
A Phase I/II Trial of BAY 43-9006 in Combination With Bevacizumab in Patients With Advanced Renal Cancer
CLINICAL_TRIALS study record update · 2013-06-05
A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Advanced Renal Cell Cancer
CLINICAL_TRIALS study record update · 2013-05-03
A Phase 1 Study of 5-azacitidine in Combination With Interferon-Alfa 2B in Unresectable or Metastatic Melanoma and Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2013-05-03
A Phase I Study of Intravenous CCI-779 in Combination With Bryostatin-1 in Solid Tumors (10038414)
CLINICAL_TRIALS study record update · 2013-04-10
Phase 1 Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, NSC #707545) in Patients With Solid Tumors.
CLINICAL_TRIALS study record update · 2013-03-25
A Phase II Trial of BMS 247550 (Ixabepilone) in Advanced Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2013-03-08
A Phase 1 Study of AZD2171 and WBRT in Patients With Brain Metastases
CLINICAL_TRIALS study record update · 2013-02-28
A Phase I Trial of Herceptin and Interleukin-12
CLINICAL_TRIALS study record update · 2013-02-28
A Phase II Study of the RAF-Kinase Inhibitor BAY 43-9006 (NSC-724772, IND-69,896) in Combination With Interferon-Alpha 2B in Patients With Advanced Renal Cancer